↓ Skip to main content

Involvement of Seladin-1 in goniothalamin-induced apoptosis in urinary bladder cancer cells

Overview of attention for article published in BMC Complementary Medicine and Therapies, August 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
4 X users
googleplus
1 Google+ user

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Involvement of Seladin-1 in goniothalamin-induced apoptosis in urinary bladder cancer cells
Published in
BMC Complementary Medicine and Therapies, August 2014
DOI 10.1186/1472-6882-14-295
Pubmed ID
Authors

Heng Kai Yen, Afifah-Radiah Fauzi, Laily Bin Din, Valerie J McKelvey-Martin, Chan Kok Meng, Salmaan Hussain Inayat-Hussain, Nor Fadilah Rajab

Abstract

Selective Alzheimer Disease Indicator-1 (or Seladin-1) is a multifunctional protein first discovered by downregulation of its expression in Alzheimer's disease. Interestingly, the expression of this protein is upregulated in several cancers, including primary bladder cancer. However, its role in cancer formation has yet to be discovered. Goniothalamin is a natural product that has been demonstrated to induce apoptosis in various cancer cell lines. In this study, we have elucidated the role of Seladin-1 in goniothalamin-induced cytotoxicity towards human urinary bladder cancer cell line RT4.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 25%
Lecturer 3 13%
Student > Master 3 13%
Student > Bachelor 2 8%
Other 2 8%
Other 4 17%
Unknown 4 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 29%
Agricultural and Biological Sciences 5 21%
Pharmacology, Toxicology and Pharmaceutical Science 4 17%
Psychology 2 8%
Medicine and Dentistry 1 4%
Other 1 4%
Unknown 4 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2014.
All research outputs
#6,779,055
of 22,759,618 outputs
Outputs from BMC Complementary Medicine and Therapies
#1,076
of 3,621 outputs
Outputs of similar age
#64,768
of 230,536 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#34
of 112 outputs
Altmetric has tracked 22,759,618 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,621 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,536 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.